Study GSI-136 in Healthy Young and Healthy Elderly Subjects

Summary

This is a first-in-humans study of GSI-136, a drug being developed for the treatment of Alzheimer Disease. The main purpose of this study is to determine whether GSI-136 is safe and tolerable in healthy young and healthy elderly subjects. The amount of drug in the body and the effects of the drug on the body will also be evaluated at certain timepoints.

Timeline

Start

2008-03

Primary completion

2008-08

Completion

2008-08

Drugs

Indications